DV Biomed Co., Ltd. (TPEX:6539)
Taiwan · Delayed Price · Currency is TWD 36.20
0.00 (0.00%)
Nov 10, 2026, 9:00 AM CST
DV Biomed Market Cap
DV Biomed has a market cap or net worth of 881.44 million as of November 10, 2026. It is the 34,568th most valuable company in the world and the 2,072nd biggest in Taiwan. Its market cap has decreased by 35.36% in one year.
Market Cap
881.44M
Enterprise Value
565.54M
Revenue
795.19M
Global Rank
Country Rank
#2,072 Taiwan
PE Ratio
11.51
ChartMarket Cap Chart
Since October 15, 2015, DV Biomed's market cap has decreased from 5.01B to 881.44M, a decrease of -82.40%. That is a compound annual growth rate of -14.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 973.97M | -32.20% |
| Dec 31, 2025 | 1.44B | 11.93% |
| Dec 30, 2024 | 1.28B | -55.96% |
| Dec 29, 2023 | 2.91B | -11.33% |
| Dec 30, 2022 | 3.29B | -5.52% |
| Dec 30, 2021 | 3.48B | -17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Johnson Chemical Pharmaceutical Works | 1.77B |
| Tien Liang BioTech | 1.58B |
| GeneFerm Biotechnology | 1.12B |
| Excelsior Biopharma | 1.11B |
| Prince Pharmaceutical | 971.78M |
| Anxo Pharmaceutical | 951.50M |
| Mediera | 811.23M |
| Winston Medical Supply | 676.72M |